Research Paper Volume 15, Issue 11 pp 4963—4985
FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response
Figure 7. FDX1 silencing inhibits the progression of glioma. (A) Western blot of FDX1 expression in endogenous FDX1-knockdown U87 and U251 cell lines. (B) qRT-PCR indicating FDX1 knockout in U87 and U251 cell lines. (C) Scratch assay showing that FDX1 silencing inhibits migration ability. (D, E) Transwell assay indicating that FDX1 silencing suppresses migration and invasion ability in glioma cells.